182 related articles for article (PubMed ID: 27281081)
1. National trends in off-label use of atypical antipsychotics in children and adolescents in the United States.
Sohn M; Moga DC; Blumenschein K; Talbert J
Medicine (Baltimore); 2016 Jun; 95(23):e3784. PubMed ID: 27281081
[TBL] [Abstract][Full Text] [Related]
2. Comparative treatment patterns, resource utilization, and costs in stimulant-treated children with ADHD who require subsequent pharmacotherapy with atypical antipsychotics versus non-antipsychotics.
Sikirica V; Pliszka SR; Betts KA; Hodgkins P; Samuelson T; Xie J; Erder H; Dammerman R; Robertson B; Wu EQ
J Manag Care Pharm; 2012; 18(9):676-89. PubMed ID: 23206211
[TBL] [Abstract][Full Text] [Related]
3. Treatment Patterns, Health Care Resource Utilization, and Health Care Cost Associated with Atypical Antipsychotics or Guanfacine Extended Release in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in Quebec, Canada.
Lachaine J; Ben Amor L; Pringsheim T; Burns J; van Stralen J
J Child Adolesc Psychopharmacol; 2019 Dec; 29(10):730-739. PubMed ID: 31433205
[No Abstract] [Full Text] [Related]
4. Treatment patterns, resource use, and economic outcomes associated with atypical antipsychotic prescriptions in children and adolescents with attention-deficit hyperactivity disorder in quebec.
Lachaine J; De G; Sikirica V; Van Stralen J; Hodgkins P; Yang H; Heroux J; Ben Amor L
Can J Psychiatry; 2014 Nov; 59(11):597-608. PubMed ID: 25565476
[TBL] [Abstract][Full Text] [Related]
5. Antipsychotic use at adult ambulatory care visits by patients with mental health disorders in the United States, 1996-2003: national estimates and associated factors.
Sankaranarayanan J; Puumala SE
Clin Ther; 2007 Apr; 29(4):723-41. PubMed ID: 17617297
[TBL] [Abstract][Full Text] [Related]
6. Impact of atypical antipsychotic use among adolescents with attention-deficit/hyperactivity disorder.
Sikirica V; Pliszka SR; Betts KA; Hodgkins P; Samuelson TM; Xie J; Erder MH; Dammerman RS; Robertson B; Wu EQ
Am J Manag Care; 2014 Sep; 20(9):711-21. PubMed ID: 25365746
[TBL] [Abstract][Full Text] [Related]
7. Trends in off-label use of antipsychotic medications among Texas Medicaid children and adolescents from 2013 to 2016.
Chen S; Barner JC; Cho E
J Manag Care Spec Pharm; 2021 Aug; 27(8):1035-1045. PubMed ID: 34337993
[No Abstract] [Full Text] [Related]
8. Antipsychotic prescribing for behavioral disorders in US youth: physician specialty, insurance coverage, and complex regimens.
Burcu M; Safer DJ; Zito JM
Pharmacoepidemiol Drug Saf; 2016 Jan; 25(1):26-34. PubMed ID: 26507224
[TBL] [Abstract][Full Text] [Related]
9. Outpatient treatment of children and adolescents with antipsychotic drugs in Croatia.
Maršanić VB; Dodig-Ćurković K; Juretić Z
Nord J Psychiatry; 2012 Feb; 66(1):2-7. PubMed ID: 21306199
[TBL] [Abstract][Full Text] [Related]
10. Outpatient antipsychotic drug use in children and adolescents in Germany between 2004 and 2011.
Schröder C; Dörks M; Kollhorst B; Blenk T; Dittmann RW; Garbe E; Riedel O
Eur Child Adolesc Psychiatry; 2017 Apr; 26(4):413-420. PubMed ID: 27623818
[TBL] [Abstract][Full Text] [Related]
11. [Use of atypical antipsychotics in Charles Perrens psychiatric hospital (Bordeaux) analysis of prescribing practices for Amisulpride, Clozapine, Olanzapine and Risperidone].
Bret P; Bonnet F; Bret MC; Jaffré A
Encephale; 2002; 28(4):329-42. PubMed ID: 12232542
[TBL] [Abstract][Full Text] [Related]
12. Off-label use of second-generation antipsychotic agents among elderly nursing home residents.
Kamble P; Sherer J; Chen H; Aparasu R
Psychiatr Serv; 2010 Feb; 61(2):130-6. PubMed ID: 20123817
[TBL] [Abstract][Full Text] [Related]
13. Trends in prescribing of antipsychotic medications for US children.
Cooper WO; Arbogast PG; Ding H; Hickson GB; Fuchs DC; Ray WA
Ambul Pediatr; 2006; 6(2):79-83. PubMed ID: 16530143
[TBL] [Abstract][Full Text] [Related]
14. Atypical antipsychotic initiation and the risk of type II diabetes in children and adolescents.
Sohn M; Talbert J; Blumenschein K; Moga DC
Pharmacoepidemiol Drug Saf; 2015 Jun; 24(6):583-91. PubMed ID: 25808613
[TBL] [Abstract][Full Text] [Related]
15. Psychotropic drug use among preschool children in the Medicaid program from 36 states.
Garfield LD; Brown DS; Allaire BT; Ross RE; Nicol GE; Raghavan R
Am J Public Health; 2015 Mar; 105(3):524-9. PubMed ID: 25602884
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Young People With Antipsychotic Medications in the United States.
Olfson M; King M; Schoenbaum M
JAMA Psychiatry; 2015 Sep; 72(9):867-74. PubMed ID: 26132724
[TBL] [Abstract][Full Text] [Related]
17. Concomitant antipsychotic prescribing in US outpatient settings.
Aparasu RR; Jano E; Bhatara V
Res Social Adm Pharm; 2009 Sep; 5(3):234-41. PubMed ID: 19733824
[TBL] [Abstract][Full Text] [Related]
18. Antipsychotic prescriptions in a university hospital outpatient population in Turkey: a retrospective database analysis, 2005-2006.
Atik L; Erdogan A; Karaahmet E; Saracli O; Atasoy N; Kurcer MA; Balcioglu I
Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):968-74. PubMed ID: 18243462
[TBL] [Abstract][Full Text] [Related]
19. A population-based study of antipsychotic prescription trends in children and adolescents in British Columbia, from 1996 to 2011.
Ronsley R; Scott D; Warburton WP; Hamdi RD; Louie DC; Davidson J; Panagiotopoulos C
Can J Psychiatry; 2013 Jun; 58(6):361-9. PubMed ID: 23768264
[TBL] [Abstract][Full Text] [Related]
20. Trends of outpatient prescription drug utilization in US children, 2002-2010.
Chai G; Governale L; McMahon AW; Trinidad JP; Staffa J; Murphy D
Pediatrics; 2012 Jul; 130(1):23-31. PubMed ID: 22711728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
